The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Accelerate late-phase drug development with continuous manufacturing
Webinar On Demand
The process development of oral solid dosage forms occurs across multiple phases. The final scaled up process is not typically finalized until shortly before filing for commercial approval. Continuous manufacturing is well suited for phase III development and clinical manufacturing and enables late-phase development by ensuring a greater quality assurance and reducing API usage. Additionally, continuous manufacturing doesn’t require scale up and expedites readiness from phase III to commercial.
Download this on-demand webinar, to hear industry expert, Doug Hausner discuss:
- Building and executing a late-phase strategy that reduces total cost of ownership
- Shortening scale-up activities to get to market quicker
- Evaluating a build vs outsourcing continuous manufacturing model
- Case studies